Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05385718 · ClinicalTrials.gov registry record
Ezra Faster Scan Study
A clinical trial of Healthy and Cancer, sponsored by Ezra AI.
- Completed
- Registry status
- 694
- Enrollment target
- 5
- Study locations
NCT05385718: Completed study of Healthy and Cancer, sponsored by Ezra AI.
NCT05385718 is a study of Healthy and Cancer that has completed, run by Ezra AI. The registered enrollment target is 694 participants, roughly in line with the 647-participant average among 1,090 other Healthy trials with a reported enrollment target. The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05385718, a study of Healthy and Cancer, has completed, sponsored by Ezra AI.
- COMPLETED
- Registry status
- 694 participants
- Enrollment target
- 5
- Study locations
Study Summary
The Ezra Faster Scan study uses non-invasive magnetic resonance imaging (MRI) technology that can "visually" detect early and late-stage cancer, and other pathologies. MRIs use a magnetic field and radio waves to create a 3-dimensional (3D) image of an individual's body without using ionizing radiation. The purpose of this research is to decrease the amount of time required by an individual to complete an early cancer screening comprehensive magnetic resonance imaging (MRI) scan, such as the Ezra Full Body MRI imaging scan. If the time required to conduct a comprehensive scan is reduced, the cost of the scan may also decrease. By decreasing consumer costs and time, more individuals may be able to afford MRI-based early cancer screening technology. Participants in this study will undergo a minimum 30-minute MRI session. These sessions will be used to evaluate new MRI "instructions" that allow for a faster MRI scan time. The images will also be used to develop mathematical models or machine learning tools that allow images to be enhanced. By enhancing images using machine learning, they may be restored to a quality typically observed in MRI sessions with longer scan (acquisition) times. To read more about the study, potential participants may review the informed consent form located below in the References section. Potential participants may email research.fasterscan@ezra.com, or call 516.340.1221. See study Eligibility Criteria below.
Conditions Studied
Interventions
- OTHER Magnetic Resonance Imaging
Study Locations (5)
California
- Various Locations - Beverly Hills
- Various Locations - Chino Hills
- Various Locations - Irvine
- Various Locations - Los Gatos
New York
- Various Locations - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 694 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2025-02-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05385718
The ClinicalTrials.gov registry entry for NCT05385718 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 694 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 647-participant average among 1,090 other Healthy trials with a reported enrollment target. The listed sponsor is Ezra AI, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Imaging is the first listed.
NCT05385718 reports 5 study locations spanning 2 distinct geographic areas - top geographies include California, New York.
Frequently Asked Questions
What is clinical trial NCT05385718 about?
NCT05385718 is a clinical study titled "Ezra Faster Scan Study". The Ezra Faster Scan study uses non-invasive magnetic resonance imaging (MRI) technology that can "visually" detect early and late-stage cancer, and other pathologies. MRIs use a magnetic field and radio waves to create a 3-dimensional (3D) image of an individual's body without using ionizing radiat...
What is the current status of trial NCT05385718?
This trial is currently completed. The enrollment target is 694 participants. The study started on 2022-06-01. Estimated completion is 2025-02-24.
What conditions does trial NCT05385718 study?
This clinical trial studies the following conditions: Healthy, Cancer, Medical Oncology.
What interventions are being tested in trial NCT05385718?
The interventions under investigation include: Magnetic Resonance Imaging (OTHER).
Who is sponsoring clinical trial NCT05385718?
This trial is sponsored by Ezra AI, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05385718 being conducted?
This trial has 5 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.